Tele: 561.316.3330

Breaking Medical Device Industry News

Friday, October 22, 2021



Gynesonics Names Robert Brown CFO

Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Robert Brown has joined the company as Chief Financial Officer, starting immediately.

Mr. Brown’s background includes significant experience successfully scaling business in healthcare, including medical devices.  He most recently served as President and CEO for Ximedica, LLC and has been active in finance roles for the past 35 years including serving as CFO of NxStage Medical, Inc. where he was an integral member contributing to the high growth revenue ramp of the organization.  Prior to NxStage Medical, Mr. Brown spent more than 10 years at Boston Scientific Corporation holding leadership roles in finance supporting strategic initiatives.  He also worked at United Technologies Corporation with responsibility for worldwide financial reporting, and at Deloitte and Touche in their audit and management consulting businesses.  Mr. Brown is a CPA and holds a MBA in Finance and International Business from the University of Michigan and a Bachelor of Business Administration in Accounting from the University of Toledo.

I am pleased to welcome Robert to the Gynesonics team,” said Gynesonics President and Chief Executive Officer, Christopher Owens.  “Robert brings to Gynesonics a wealth of proven experience in driving scale and creating high growth strategic value.  As we accelerate the commercial launch of our Sonata® System, his experience at the leadership level will play a vital role in supporting and driving our global success.”

“I am incredibly excited to join the Gynesonics team,” said Mr. Brown.  “The Sonata System is not only a unique and breakthrough technology, but the company’s focus on developing robust clinical data and establishing payer coverage is proving to be the correct strategy to accelerate adoption and bring this treatment to women worldwide.  In the U.S. alone, over 8 million women annually avoid traditional surgical treatment for their uterine fibroid issues.  I look forward to utilizing my experience to help bring Sonata to this $4 billion-plus global market.”

Other Articles

Zerigo Health Raises $43 Million in Series B Funding

This round will allow Zerigo Health to respond to the increasing demand for its innovative connected chronic skin condition solution for the over 40 million Americans living with psoriasis, vitiligo, and eczema.

DentalMonitoring, the Leading AI-Based Dental Software Company, Announces a $150 Million Growth Financing, Reaching a Valuation Over $1 Billion

The round is led by a new investment of $90 million from Mérieux Equity Partners and $60 million from Vitruvian Partners, an existing financial investor, demonstrating confidence in the company’s ambitious plans.

Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company

This infusion of capital will support the initiation of a first-in-human trial of ADAM™, the world’s first hydrogel implant designed to provide long-lasting, non-permanent contraception for men.

Endolumik Inc. of Morgantown Secures $175,000 Angel Investment from Country Roads Angel Network

Endolumik, Inc. was founded in May 2020 by Mara McFadden, chief executive officer, and Dr. Nova Szoka, inventor of the surgical device.

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

By using this website you agree to accept Medical Device News Magazine Privacy Policy